Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide

Mamta Parikh, Catherine Tangen, Maha H.A. Hussain, Shilpa Gupta, Sam Callis, Yeonjung Jo, Andrea Harzstark, Channing J. Paller, Saby George, Matthew R. Zibelman, Heather H. Cheng, Benjamin L. Maughan, Jingsong Zhang, Russell K. Pachynski, Alan H. Bryce, Daniel W. Lin, David I. Quinn, Seth P. Lerner, Ian M. Thompson, Tanya B. DorffPrimo N. Lara, Neeraj AgarwalShow 2 othersShow less